STOCK TITAN

[Form 4/A] NATIONAL HEALTH INVESTORS INC Amended Insider Trading Activity

(Neutral)
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

PASCOE KEVIN CARLTON reported acquisition or exercise transactions in this Form 4 filing.

National Health Investors Inc. reported that Chief Investment Officer Kevin Carlton Pascoe received a grant of 4,726 shares of common stock on March 3, 2026, at no cash cost to him. After this compensation-related award, he directly holds 73,082 common shares.

The filing is an amended Form 4 that corrects an earlier administrative error, which had overstated the number of shares awarded on that date by 346 shares. This amendment updates the record to show the accurate number of shares granted.

Positive

  • None.

Negative

  • None.
Insider PASCOE KEVIN CARLTON
Role Chief Investment Officer
Type Security Shares Price Value
Grant/Award Common Stock 4,726 $0.00 $0.00
Holdings After Transaction: Common Stock — 73,082 shares (Direct)
Footnotes (1)
  1. F1. Due to an administrative error, the number of securities reported as awarded to the Reporting Person on March 3, 2026 was overstated by 346 shares. This Form 4/A is being filed to report the correct number of securities awarded.
Shares granted 4,726 shares Common stock award on March 3, 2026
Price per share for award $0.0000 per share Indicates compensation grant, not market purchase
Shares held after transaction 73,082 shares Direct ownership following March 3, 2026 grant
Prior overstatement amount 346 shares Earlier award count overstated by this amount
Form 4/A regulatory
"This Form 4/A is being filed to report the correct number"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
administrative error other
"Due to an administrative error, the number of securities reported"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Chief Investment Officer financial
"officer_title": "Chief Investment Officer""
A chief investment officer (CIO) is the person responsible for managing a company or organization’s investments and financial strategies. They make key decisions about where to put money to help grow wealth or achieve financial goals, much like a coach plans a team’s game strategy. Their work matters to investors because it influences how effectively an organization’s assets are used to generate returns.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did NHI Chief Investment Officer Kevin Pascoe report?

Kevin Pascoe reported receiving a grant of 4,726 shares of National Health Investors common stock. The shares were awarded as compensation, not purchased in the market, and increased his direct holdings to 73,082 shares after the transaction.

Why did National Health Investors (NHI) file an amended Form 4/A?

The amended Form 4/A corrects an earlier administrative error in the reported award to Kevin Pascoe. The prior filing overstated the number of shares granted by 346, and this amendment updates the record to reflect the accurate 4,726-share grant.

How many NHI shares does Kevin Pascoe hold after the corrected award?

After the corrected grant of 4,726 shares, Kevin Pascoe directly holds 73,082 shares of National Health Investors common stock. This figure reflects his total direct ownership immediately following the March 3, 2026 compensation award.

Was cash paid for the NHI shares granted to Kevin Pascoe?

No cash was paid for the 4,726 shares granted to Kevin Pascoe. The filing shows a price per share of 0.0000, indicating a stock award given as compensation rather than a market purchase or sale transaction.

Does this NHI Form 4/A indicate any stock sales by Kevin Pascoe?

The Form 4/A does not report any stock sales by Kevin Pascoe. It shows only an acquisition of 4,726 common shares through a grant or award, with no sell transactions or derivative exercises disclosed in the provided data.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PASCOE KEVIN CARLTON

(Last)(First)(Middle)
222 ROBERT ROSE DRIVE

(Street)
MURFREESBORO TENNESSEE 37129

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Investment Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
03/05/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/03/2026A4,726(1)A$073,082D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Due to an administrative error, the number of securities reported as awarded to the Reporting Person on March 3, 2026 was overstated by 346 shares. This Form 4/A is being filed to report the correct number of securities awarded.
/s/ Kimberly V. Ouimet, by limited power of attorney03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)